All News

The Centers for Medicare and Medicaid Services has proposed a rule that would create a new standard for electronic prescriptions for the Medicare Part D program.

GSK gets OTC marketing rights from Merck for Mevacor

Changes in compounding standards take effect on June 1, 2008

A final rule from the DEA allows doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II controlled substances.

The new products include branded drugs, new formulations, new indications, and new dosing, along with OTCs and home health and beauty items.

New drugs in development for age-related macular degeneration (AMD).

Patience and cooperation have been the hallmarks of an award-winning career in Alzheimer's care for pharmacist Robert Cluxton.

Pharmacists' organizations were out in force at a recent FDA hearing on the possibility of creating a third category of drugs that would be placed "behind-the-counter" and pharmacist-assisted.

This stockchecker from Hamacher discusses family planning products.

GPhA urges state governments to increase access to generics

ASHP will hold a meeting with several other organizations to study how infusion-related errors can be eliminated.

DEA issues rule on Schedule I positional isomers

Three Take Care Health Clinics open at Walgreens in Nashville

GPhA urges state governments to increase access to generics

Healthy Actions Rx-Savings program debuts from Aetna

AARP honored by NACDS as a Community Pharmacy Great Communicator

Kentucky R.Ph.s urge passage of Fair Medicaid Drug Payment Act of 2007

Asolva develops way to document medication management and pharmacist interventions

Rxs for Xenical down since OTC Alli released

Changes made to isotretinoin iPLEDGE program

According to a survey from the Pharmacy Technician Certification Board, Americans assume that technicians have more regulation and training than most states require.

The American Health Information Community urges CMS to mandate use of e-prescriptions in Medicare.

eHealth Initiative is forming a new drug safety program, eHI Connecting Communities for Drug Safety Collaboration.

Omnicell Inc. develops system to centralize patient medications

FDA may allow distribution of off-label use information.

Intranasal desmopressin no longer indicated for PNE

Sens. John Kerry, Diane Feinstein, and Barbara Boxer urge the FDA to test lipstick for lead

At the ASHP show, Baxa Corp. rolled out a no-calibration pump and a Web-based system to keep track of drug orders.